Humana Inc. (NYSE:HUM) Receives $386.61 Average Price Target from Analysts

Humana Inc. (NYSE:HUM) has earned a consensus recommendation of “Moderate Buy” from the thirty brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $391.8696.

Several research analysts recently weighed in on HUM shares. Cantor Fitzgerald lifted their price target on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a research report on Tuesday, July 7th. Robert W. Baird set a $390.00 price objective on shares of Humana in a research note on Thursday, July 30th. HSBC lowered shares of Humana to a “hold” rating in a report on Thursday, July 30th. Guggenheim boosted their target price on shares of Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Finally, Evercore raised shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a report on Wednesday, July 29th.

Humana Price Performance

NYSE:HUM opened at $384.44 on Monday. Humana has a one year low of $163.11 and a one year high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market cap of $46.16 billion, a price-to-earnings ratio of 36.37, a PEG ratio of 2.20 and a beta of 0.72. The firm’s fifty day moving average is $377.18 and its two-hundred day moving average is $271.64.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the firm earned $6.27 EPS. The firm’s revenue for the quarter was up 26.2% compared to the same quarter last year. Research analysts expect that Humana will post 9.08 EPS for the current year.

Institutional Investors Weigh In On Humana

Several hedge funds have recently modified their holdings of HUM. BlackRock Inc. purchased a new position in Humana during the second quarter worth approximately $4,138,160,000. Pzena Investment Management LLC purchased a new stake in shares of Humana in the second quarter valued at approximately $1,749,014,000. Capital International Investors raised its stake in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after buying an additional 3,097,571 shares during the period. Norges Bank purchased a new position in shares of Humana during the 4th quarter valued at approximately $456,632,000. Finally, Wellington Management Group LLP grew its stake in Humana by 4,481.7% in the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after acquiring an additional 1,170,387 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.